ABIOMED June 15th Short Interest Update

ABIOMED (NASDAQ:ABMD) reported a drop of 1.3% or 38,843 shares in its short interest. The short figure came in at 7.3% of the total floats. The average daily volume of 410,630 shares suggests that the days to cover 2,927,668 short positions, as on June 15,2016, will be 7. On May 31,2016, the short interest was 2,966,511 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 24th after market close.

ABIOMED (NASDAQ:ABMD): The stock opened at $99.00 on Friday but the bulls could not build on the opening and the stock topped out at $103.98 for the day. The stock traded down to $98.01 during the day, due to lack of any buying support eventually closed down at $100.37 with a loss of -3.72% for the day. The stock had closed at $104.25 on the previous day. The total traded volume was 4,664,903 shares.

The company shares have rallied 53.64% from its 1 Year high price. On Aug 13, 2015, the shares registered one year high at $110.68 and the one year low was seen on Jul 8, 2015. The 50-Day Moving Average price is $99.53 and the 200 Day Moving Average price is recorded at $91.11.

ABIOMED (NASDAQ:ABMD) has climbed 1.15% in the past week and advanced 0.63% in the last 4 weeks. In the past week, the company has outperformed the S&P 500 by 2.83% and the outperformance has advanced to 3.68% for the last 4 weeks period.

Abiomed, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Companys products include Impella 2.5, a percutaneous micro heart pump with an integrated motor and sensors; Impella CP, which is primarily used by either interventional cardiologists to support patients in the catheter lab or by surgeons in the heart surgery suite; Impella 5.0 and Impella LD, a percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump that is designed to allow greater than four liters of flow per minute; AB5000, a circulatory support system for the temporary support of acute heart failure patients in profound shock, and Symphony, a minimally invasive implantable cardiac assist device.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.